Louis Jacques, MD
Thoracic Surgery (Cardiothoracic Vascular Surgery) · Edina, MNNPI 1700816998
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $29,265 of the $35,751 with a category attached, or 81.9%. AstraZeneca accounts for 94.9% of it on its own, with 4 other manufacturers making up the rest. Among thoracic surgery (cardiothoracic vascular surgery) clinicians in MN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 37 payments — averaging $966.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$34K
- Medtronic$2K
- AbbVie$120
- GSK$98
- Davol Inc.$48
What the payments were for
- Consulting fees$4,65013%
- Speaking & faculty fees$29,26582%
- Grants$1200%
- Travel & lodging$1,0533%
- Food & beverage$6632%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 32 | $33,910 |
| Medtronic | 1 | $1,575 |
| AbbVie | 1 | $120 |
| GSK | 2 | $98 |
| Davol Inc. | 1 | $48 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TAGRISSO$24,389
- IMFINZI$3,495
- NATRELLE SALINE-FILLED BREAST IMPLANTS$120
- REVOLVE$120
How this compares
$35,751 in reported general payments places this provider in the 95th percentile of 128 thoracic surgery (cardiothoracic vascular surgery) providers in Minnesota.
See all thoracic surgery (cardiothoracic vascular surgery) providers in Minnesota →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydromorphone Hcl | 19 | $104 |
Paid to pharmacies, not to this prescriber.
Other thoracic surgery (cardiothoracic vascular surgery) in Edina
- Melissa KorbEdina$11K
- Vinayak BapatMinneapolis$792K
- Benjamin SunMinneapolis$443K
- Malakh ShresthaRochester$89K
- Juan CrestanelloRochester$56K
- Janani ReisenauerRochester$46K
- Nader MoazamiMinneapolis$28K
- Sarah PalmerMinneapolis$28K
- Matthew GraczykMinneapolis$28K
- Amit BhargavaMinneapolis$27K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.